Generation of HIV-1/HIV-2 cross-reactive peptide antisera by small sequence changes in HIV-1 reverse transcriptase...

Area of Science:

• Immunology
• Virology
• Biochemistry

Background:

• Human immunodeficiency virus (HIV) exists as distinct types, HIV-1 and HIV-2.
• Developing effective diagnostic tools and vaccines requires understanding the immune response to viral proteins like reverse transcriptase (RT) and integrase (IN).

Purpose of the Study:

• To investigate the specificity of immune responses against HIV-1 and HIV-2 reverse transcriptase (RT) and integrase (IN) proteins.
• To explore strategies for generating cross-reactive diagnostic reagents and dual-specificity vaccines against both HIV types.

Main Methods:

• Synthesis of peptides representing homologous regions of HIV-1 and HIV-2 RT and IN.
• Generation of peptide antisera in rabbits by immunizing with synthesized peptides.
• Assays to evaluate integrase (IN) activity and Western blot analysis to assess antibody specificity and cross-reactivity.

Main Results:

• HIV-1 and HIV-2 IN peptide antisera demonstrated inhibitory activity in 3' processing assays, while anti-RT sera did not inhibit RT activity.
• HIV-2 antisera cross-reacted with both HIV-2 and HIV-1 proteins, whereas HIV-1 antisera were type-specific.
• Modification of HIV-1 peptides with minimal changes (as few as two amino acids) to mimic HIV-2 sequences induced cross-reactive antisera.

Conclusions:

• The immune response to HIV proteins can be modulated to achieve cross-reactivity between HIV-1 and HIV-2.
• These findings suggest novel approaches for developing diagnostic reagents capable of detecting both HIV-1 and HIV-2.
• The study provides a framework for designing HIV peptide vaccines with dual specificity against HIV-1 and HIV-2.